EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
189 hedge funds and large institutions have $1.07B invested in Eagle Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 80 increasing their positions, 42 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $1.16B → $1.07B (-$95.3M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
189
Holding in Top 10
3
Calls
$18.7M
Puts
$16.3M
Top Buyers
| 1 | +$21.5M | |
| 2 | +$19.7M | |
| 3 | +$8.75M | |
| 4 |
MCM
Matarin Capital Management
New York
|
+$6.74M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$5.16M |
Top Sellers
| 1 | -$34.9M | |
| 2 | -$25.1M | |
| 3 | -$24.4M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$10.8M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$6.79M |